Source: Cancer Research. Conference titles: AACR Special Conference on Translational Control of Cancer: A New Frontier in Cancer Biology and Therapy. Unidade: FM
Subjects: FENÓTIPOS, NEOPLASIAS MAMÁRIAS, EXPRESSÃO GÊNICA
ABNT
RAVACCI, G. R. et al. HER2-associated lipogenic phenotype as a potential therapeutical target in breast cancer patients. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445. Acesso em: 04 jun. 2024. , 2017APA
Ravacci, G. R., Santos, J. R., Brentani, M. M., Tortelli, T., Dale, I., Logullo, A. F., & Waitzberg, D. L. (2017). HER2-associated lipogenic phenotype as a potential therapeutical target in breast cancer patients. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445NLM
Ravacci GR, Santos JR, Brentani MM, Tortelli T, Dale I, Logullo AF, Waitzberg DL. HER2-associated lipogenic phenotype as a potential therapeutical target in breast cancer patients [Internet]. Cancer Research. 2017 ; 77( 4):[citado 2024 jun. 04 ] Available from: https://doi.org/10.1158/1538-7445Vancouver
Ravacci GR, Santos JR, Brentani MM, Tortelli T, Dale I, Logullo AF, Waitzberg DL. HER2-associated lipogenic phenotype as a potential therapeutical target in breast cancer patients [Internet]. Cancer Research. 2017 ; 77( 4):[citado 2024 jun. 04 ] Available from: https://doi.org/10.1158/1538-7445